Dilraj S. Grewal

6 days ago | healio.com | Dilraj S. Grewal |Anthony DeFino

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS,provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed trials, others demonstrated promising results, including dazdotuftide (Tarsier Pharma), which reduced inflammation in patients with uveitis without raising IOP in a phase 3 trial.

Dec 4, 2024 | healio.com | Dilraj S. Grewal |Anthony DeFino |Christine Klimanskis

Read more You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Jul 29, 2024 | healio.com | Dilraj S. Grewal |Alex Young |Anthony DeFino |Christine Klimanskis

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this Healio Video Perspective from the ASRS annual meeting, Dilraj Grewal, MD, FASRS, discusses eyes that developed macular neovascularization in the GATHER trials.

Feb 27, 2024 | retina-specialist.com | Dilraj S. Grewal

BiosDr. Grewal is an associate professor of ophthalmology at Duke University. Dr. Thomas is a partner in vitreoretinal surgery and uveitis at Tennessee Retina. DISCLOSURES: Dr. Grewal is a consultant to Iveric Bio, Regeneron, DORC, Alimera and Apellis. Dr. Thomas is a consultant to Allergan/AbbVie, Alimera Sciences, Avesis, EyePoint Pharmaceuticals, Genentech/Roche and Novartis.

Oct 21, 2023 | healio.com | Dilraj S. Grewal |Anthony DeFino |Christine Klimanskis

You've successfully added Ophthalmology: Retina/Vitreous to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].